In addition, reduced expression of PGRN decreased IL-6–stimulated proliferation, migration and invasion of HepG2 cells, which suggests that PGRN may contribute to the IL-6–mediated malignancy of HCC cells, at least in part. This evidence concerns the gene IL6 and hepatocellular carcinoma.